Loading clinical trials...
Loading clinical trials...
OPTImal Number of Pleural BIOPsies During Pleuroscopy
A single-center, non-randomized, prospective observational, pilot study designed to determine what is the optimal number of pleural biopsies to take during pleuroscopy.
After enrollment, participants will undergo pleural biopsies via pleuroscopy. Specimens will be divided into three aliquots (1-3, 4-6, 7-10), which will be sent to pathology. A designated pathologist will evaluate the specimens in each aliquot to determine the number of biopsies required to reach a diagnosis and to obtain sufficient material for biomarker testing (when needed), and determine whether analysis of further aliquots is needed.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Mount Sinai Hospital
New York, New York, United States
Start Date
December 5, 2024
Primary Completion Date
December 18, 2025
Completion Date
December 18, 2025
Last Updated
February 4, 2026
104
ACTUAL participants
Lead Sponsor
Icahn School of Medicine at Mount Sinai
NCT06741839
NCT03213834
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04538235